A novel high throughput screening platform reveals an optimised cytokine formulation for human hematopoietic progenitor cell expansion.

The main limitations of hematopoietic cord blood (CB) transplantation, viz. low cell dosage and delayed reconstitution, can be overcome by ex-vivo expansion. CB expansion under conventional culture causes the rapid cell differentiation and depletion of hematopoietic stem/progenitor cells (HSPC) resp...

詳細記述

書誌詳細
主要な著者: Tarunina, M, Hernandez, D, Kronsteiner-Dobramysl, B, Pratt, P, Watson, T, Hua, P, Gullo, F, Van der Garde, M, Zhang, Y, Hook, L, Choo, Y, Watt, S
フォーマット: Journal article
言語:English
出版事項: Mary Ann Liebert, Inc 2016

類似資料